| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Evofem Biosciences, Inc. (EVFM) has 0 insiders with recent SEC Form 4 filings, including 10 buys and 4 sells. EVFM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 21, 2019 | Kamdar Kim P. | Director | Sell | 655 | $5.07 | $3,320.85 | -100% | |
| Feb 8, 2019 | Invesco Ltd. | 10% Owner | Buy | 425,531 | $2.64 | $1,123,401.84 | +4.6% | |
| Nov 21, 2018 | Barrans Russell | Chief Commercial Officer | Buy | 279 | $3.55 | $990.45 | +2.2% | |
| Aug 21, 2018 | Fitzpatrick Alexander A83 | General Counsel And Secretary | Buy | 5,000 | $2.21 | $11,035.00 | +3.5% | |
| Aug 16, 2018 | Culwell Kelly | Chief Medical Officer | Buy | 3,000 | $2.24 | $6,720.00 | +33.4% | |
| Aug 15, 2018 | Lynch Thomas G | Director | Buy | 100,000 | $2.26 | $225,853.67 | +55.2% | |
| Aug 10, 2018 | Barrans Russell | Chief Commercial Officer | Buy | 3,715 | $1.98 | $7,355.70 | +42.1% | |
| Aug 10, 2018 | Pelletier Saundra L | Chief Executive Officer | Buy | 10,000 | $2.11 | $21,100.00 | +3.0% | |
| May 22, 2018 | Invesco Ltd. | 10% Owner | Buy | 2,127,659 | $4.69 | $9,978,720.71 | +30.2% | |
| Dec 30, 2015 | Alta Partners Viii, L.P. | Former 10% Owner | Sell | 797,987 | $1.51 | $1,201,680.09 | -13.7% |